Invention Grant
- Patent Title: Pharmaceutical formulations of TNF-alpha antibodies
-
Application No.: US14383533Application Date: 2013-03-05
-
Publication No.: US10093728B2Publication Date: 2018-10-09
- Inventor: Sanjeev Kumar Mendiratta , Sanjay Bandyopadhyay , Chintan G. Patel
- Applicant: Cadila Healthcare Limited
- Applicant Address: IN Ahmedabad
- Assignee: CADILA HEALTHCARE LIMITED
- Current Assignee: CADILA HEALTHCARE LIMITED
- Current Assignee Address: IN Ahmedabad
- Agency: Goodwin Procter LLP
- Priority: IN610/MUM/2012 20120307; IN1606/MUM/2012 20120530; IN3031/MUM/2012 20121017
- International Application: PCT/IN2013/000129 WO 20130305
- International Announcement: WO2013/164837 WO 20131107
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K39/395 ; A61K9/19 ; A61K47/18 ; A61K47/26
Abstract:
The present invention provides certain improved formulations of proteins. Specifically, the present invention provides use of certain excipients that are useful for stabilization of antibody preparations. Additionally, the novel formulations of the present invention prevents the formation of aggregates or fragments or modifications of protein in solution.
Public/Granted literature
- US20150071936A1 PHARMACEUTICAL FORMULATIONS OF TNF-ALPHA ANTIBODIES Public/Granted day:2015-03-12
Information query
